Skip navigation
Skip navigation

Ant venom immunotherapy in Australia: the unmet need

Mullins, Raymond; Brown, Simon GA


Jack jumper ant (JJA) venom allergy is an important cause of anaphylaxis in south-eastern Australia. The efficacy and real-world effectiveness of JJA venom immunotherapy (VIT) to prevent anaphylaxis in allergic patients are now well established, with an evidence base that is at least equivalent to that supporting VIT for allergy to other insect species. The tolerability and safety of JJA VIT are comparable with those of honeybee VIT.

CollectionsANU Research Publications
Date published: 2014
Type: Journal article
Source: Medical Journal of Australia
DOI: 10.5694/mja13.00035
Access Rights: Open Access


File Description SizeFormat Image
01_Mullins_Ant_venom_immunotherapy_in_2014.pdf138.65 kBAdobe PDF

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator